NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating 3 out of 5 
NPSP VS S&P 500 (SPY)

NPSP News and Commentary

How do you think NPSP will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

121 Outperform
18 Underperform
 

All-Star Players

29 Outperform
4 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top NPSP Bull/Bear Pitches

zzlangerhans (99.66)
Submitted November 22, 2011

Recent bad news from the STEPS 2 extension study of Gattex in short bowel syndrome got me out of the red zone and into a winning red thumb on NPS. The company reported three cases of cancer occurring in the 37 patients who received Gattex. The… More

Fools bullish on NPSP
are also bullish on:

cashsage (30.58)
Submitted December 17, 2009

NPSP has an illiquid balance sheet and a too high valuation compared to its sales potential. It is also loss making at least until 2011.

Featured Broker Partners


Advertisement